Effects of a non-peptide CRF antagonist (DMP696) on the behavioral and endocrine sequelae of maternal separation

被引:46
作者
Maciag, CM
Dent, G
Gilligan, P
He, LQ
Dowling, K
Ko, T
Levine, S
Smith, MA
机构
[1] Dupont Merck Pharmaceut Co, CNS Dis Res, Wilmington, DE 19880 USA
[2] Dupont Merck Pharmaceut Co, Dept Chem, Wilmington, DE 19880 USA
[3] Univ Delaware, Dept Psychol, Newark, DE USA
关键词
corticotropin relensing factor; maternal separation; stress; antagonist; plus maze; ACTH; rat;
D O I
10.1016/S0893-133X(01)00398-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We examined whether blockade of corticotropin-releasing factor (CRF) receptors by a non-peptide CRF antagonist (DMP696) would attenuate the stress hyper-responsiveness that occurs in response to maternal separation. In a social interaction test as well as the elevated plus maze, adult male rats, which had been maternally separated as infants, displayed more anxiety-like behavior compared with handled rats. DMP696 increased social interaction in both groups. In the elevated plus maze however, DMP696 significantly increased open arm time in the maternally separated rats but not in the handled group whereas chlordiazepoxide increased open arm time in both groups. DMP696 also appeared to block stress-induced ACTH secretion more readily in the maternally separated group compared with the handled rats. These observations suggest that CRF antagonists are particularly effective in animals are hyper-responsive to stress and may therefore have utility in the treatment of anxiety and affective disorders where CRF has been implicated. (C) 2002 American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
引用
收藏
页码:574 / 582
页数:9
相关论文
共 31 条
[1]   Childhood abuse and neglect: Specificity of effects on adolescent and young adult depression and suicidality [J].
Brown, J ;
Cohen, P ;
Johnson, JG ;
Smailes, EM .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1999, 38 (12) :1490-1496
[2]   The effects of early rearing environment on the development of GABAA and central benzodiazepine receptor levels and novelty-induced fearfulness in the rat [J].
Caldji, C ;
Francis, D ;
Sharma, S ;
Plotsky, PM ;
Meaney, MJ .
NEUROPSYCHOPHARMACOLOGY, 2000, 22 (03) :219-229
[3]   MOUSE STRAIN DIFFERENCES IN THE BEHAVIORAL-EFFECTS OF CORTICOTROPIN-RELEASING FACTOR (CRF) AND THE CRF ANTAGONIST ALPHA-HELICAL CRF(9-41) [J].
CONTI, LH ;
COSTELLO, DG ;
MARTIN, LA ;
WHITE, MF ;
ABREU, ME .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 48 (02) :497-503
[4]  
CURTIS AL, 1994, J PHARMACOL EXP THER, V268, P359
[5]   The role of corticotropin-releasing factor-norepinephrine systems in mediating the effects of early experience on the development of behavioral and endocrine responses to stress [J].
Francis, DD ;
Caldji, C ;
Champagne, F ;
Plotsky, PM ;
Meaney, MJ .
BIOLOGICAL PSYCHIATRY, 1999, 46 (09) :1153-1166
[6]  
GILLIGAN PJ, 2000, J MED CHEM, V43, P1
[7]  
GORDON MK, 2001, THESIS U DELAWARE NE
[8]  
Griebel G, 1998, PSYCHOPHARMACOLOGY, V138, P55
[9]   Differential behavioral and endocrinological effects of corticotropin-releasing hormone (CRH) in the syracuse high- and low-avoidance rats [J].
Gupta, P ;
Brush, FR .
HORMONES AND BEHAVIOR, 1998, 34 (03) :262-267
[10]   4-(1,3-dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)-pyrazolo[1,5-a]-1,3,5-triazine:: A portent, orally bioavailable CRF1 receptor antagonist [J].
He, LQ ;
Gilligan, PJ ;
Zaczek, R ;
Fitzgerald, LW ;
McElroy, J ;
Shen, HSL ;
Saye, JA ;
Kalin, NH ;
Shelton, S ;
Christ, D ;
Trainor, G ;
Hartig, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (03) :449-456